Feb 3 (Reuters) - Neuren Pharmaceuticals NEU.AX:
WAS INFORMED OF A NEGATIVE TREND VOTE ON ITS MAA FOR TROFINETIDE
ACADIA TO REQUEST RE-EXAMINATION OF CHMP OPINION
ACADIA WAS INFORMED BY COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE OF EUROPEAN MEDICINES AGENCY
Further company coverage: NEU.AX
((Reuters.Briefs@thomsonreuters.com;))